November 18, 2020
Yesterday afternoon, the U.S. FDA issued an Emergency Use Authorization (EUA) to a COVID-19 molecular diagnostic test that provides individuals with a result within 30 minutes, in the comfort of their home.
As opposed to currently available at-home testing products, which have patients self-collect a nasal swab sample and ship it for processing in a lab, the Lucira COVID-19 All-in-One Test Kit...
October 28, 2020
UK high street pharmacy, Boots is launching a new in-store COVID-19 nasal swab testing service to people who are not showing symptoms.
The technology has been developed by LumiraDx, who is also providing supplies to the NHS in Scotland.
The Lumira private COVID-19 test will cost £120 and will be available in 10 stores from this week, before rolling out to 50 Boots stores throughout November.
October 27, 2020
College student health-insurer Wellfleet and binx health, an in-home infectious disease test-kit service, have teamed up to offer COVID-19 testing for college students.
Using binx’s testing platform, which was originally created for discrete at-home sexually transmitted infections testing, and by working with Wellfleet’s client campuses, the two companies are giving universities a streamlined...
October 27, 2020
Yesterday, Kaiser Health News reported that California's San Francisco and Alameda counties had "severed ties" with a highly publicized "Project Baseline" COVID-19 testing program supported by Alphabet's Verily Life Sciences.
In particular, the reporting focused on Verily-backed community testing sites located in Oakland that have been closed for months, one of which is now working to reopen with...
October 23, 2020
PAINCHEK ANNOUNCES CARE HOME CAMPAIGN
Responding to the NHSX pledge to give 11,000 iPads to UK care homes, AI-powered pain assessment company, PainChek, has announced a one-off campaign to help UK care homes benefit from its technology.
PainChek is offering all UK care homes a one-off unique voucher of up to £500 to cover the cost of product training for their staff so they can use the PainChek...
October 14, 2020
Cue Health, a rapid diagnostics startup with a connected testing device platform, has been awarded $481 million from HHS and the Department of Defense (DoD) to expand production of a COVID-19 molecular test that received an Emergency Use Authorization back in June.
According to announcements from the government and the startup, the money will be used to deliver six million COVID-19 molecular...
August 27, 2020
Abbott has scored yet another Emergency Use Authorization for rapid coronavirus testing – this one, named BinaxNOW COVID-19 Ag Card, come in the form of a card and can provide results in 15 minutes.
The other notable difference in this test is the price point. Abbott said it will sell the tests for $5 each.
Users will also be able to link their results to Abbott’s app dubbed NAVICA, which will...
August 13, 2020
Driving digital diagnosis. Roche and Israeli life sciences investment firm aMoon announced plans this week to launch an early-stage investment program called StarFinder Lab. Focused on novel diagnostic technologies, in particular, with the help of AI data analysis and digital health tools, the program will provide funding, mentoring and other strategic support such as a physical office space...
August 10, 2020
The past few months have seen tech companies, healthcare organizations, employee-benefits vendors and others toss their hat into a fast-growing market for "return-to-work" COVID-19 health-monitoring services.
Today CVS Health and Salesforce, two of the bigger names in that race, have announced plans to integrate their offerings into a single digital, data-driven testing and monitoring program....
July 27, 2020
On Friday evening, the FDA reissued an emergency use authorization (EUA) for LabCorp's COVID-19 RE-PCR Test that now allows for testing among those without any symptoms of COVID-19.
The agency also expanded the indication to allow for pooled sample testing – a technique of combining multiple samples into a single test, and then following up with individual tests should the group be positive. The...